Citrus crops are among the world's most familiar fruits, but their genomes have remained difficult to interpret because of ancient hybridization, complex ancestry, and incomplete gene annotation. 

Papaya is a nutritious and economically valuable tropical fruit, but improving it through modern breeding has long been slowed by difficult transformation procedures.

This clinical case report highlights that generalized skin hyperpigmentation, particularly at friction and pressure sites, may be the initial and most prominent sign of Addison’s disease (primary adrenal insufficiency). Early recognition of this dermatological manifestation enables timely diagnosis and life-saving treatment, preventing potentially fatal adrenal crisis.

A retrospective ultrasound study of 76 psoriasis patients shows that six weeks of secukinumab treatment significantly reduces subclinical enthesitis—early inflammation at tendon attachment sites—suggesting early IL-17A blockade may help prevent progression to psoriatic arthritis, a disabling complication affecting up to 5.8% of Chinese psoriasis patients.

Researchers clarify a long-standing diagnostic confusion by distinguishing two distinct steroid-induced facial skin conditions: steroid-induced rosacea (SIR) and steroid-induced rosacea-like dermatitis (SIRD). This new classification provides clear clinical guidance, prevents ineffective or harmful treatments, and improves outcomes for millions of patients affected by topical steroid side effects.

A rare case of basal cell carcinoma (BCC) on the right middle finger in a 63-year-old man underscores that this common skin cancer can occur in unusual digital locations. The report emphasizes that biopsy remains the gold standard for diagnosis, and clinicians should include BCC in the differential diagnosis of atypical finger lesions to ensure timely treatment.

A landmark research review confirms the scientific basis for a major update to China’s 2025 clinical guidelines, which redefine postherpetic neuralgia (PHN)—the debilitating chronic pain that follows herpes zoster—as pain persisting 1 month after lesion healing, down from the previous 3-month standard. This paradigm shift will allow millions of patients to receive timely intervention before pain becomes permanent, significantly reducing the risk of lifelong suffering.